Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 17, 2006 - Issue 6
Submit an article Journal homepage
202
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

High‐dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life

Catia De Felice Department of Dermatology, University of Rome “Tor Vergata”, Rome, ItalyCorrespondence[email protected]
,
Annamaria Mazzotta Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
,
Maria Esposito Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
,
Luca Bianchi Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
&
Sergio Chimenti Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
Pages 355-358 | Received 09 Feb 2006, Accepted 05 Jul 2006, Published online: 12 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tian Hao Zhu, Mio Nakamura, Michael Abrouk, Benjamin Farahnik, John Koo & Tina Bhutani. (2016) Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review. Journal of Dermatological Treatment 27:5, pages 406-413.
Read now
Annamaria Mazzotta, Maria Esposito, Caterina Schipani & Sergio Chimenti. (2009) Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study. Journal of Dermatological Treatment 20:6, pages 354-358.
Read now
Abby S. Van Voorhees & Richard Fried. (2009) Depression and Quality of Life in Psoriasis. Postgraduate Medicine 121:4, pages 154-161.
Read now

Articles from other publishers (10)

Frank Behrens, Lothar Meier, Jörg C. Prinz, Jürgen Jobst, Ralph Lippe, Peter-Andreas Löschmann & Hanns-Martin Lorenz. (2018) Simultaneous Response in Several Domains in Patients with Psoriatic Disease Treated with Etanercept as Monotherapy or in Combination with Conventional Synthetic Disease-modifying Antirheumatic Drugs. The Journal of Rheumatology 45:6, pages 802-810.
Crossref
Ashley L. Semble, Scott A. Davis & Steven R. Feldman. (2013) Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review. American Journal of Clinical Dermatology 15:1, pages 37-43.
Crossref
Elena Campione, Laura Diluvio, Alessandro Terrinoni, Augusto Orlandi, Maria Latino, Claudia Torti, Lucia Pietroleonardo, Elisabetta Botti, Sergio Chimenti & Luca Bianchi. (2014) Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reports. BMC Research Notes 7:1, pages 929.
Crossref
F. Navarro-Sarabia, J. L. Fernandez-Sueiro, J. C. Torre-Alonso, J. Gratacos, R. Queiro, C. Gonzalez, E. Loza, L. Linares, P. Zarco, X. Juanola, J. Roman-Ivorra, E. Martin-Mola, R. Sanmarti, J. Mulero, G. Diaz, Y. Armendariz & E. Collantes. (2011) High-dose etanercept in ankylosing spondylitis: results of a 12-week randomized, double blind, controlled multicentre study (LOADET study). Rheumatology 50:10, pages 1828-1837.
Crossref
J. Pedraz & E. Daudén. (2010) Artritis psoriásica y etanercept. Actas Dermo-Sifiliográficas 101, pages 26-34.
Crossref
Amr A. Saad, Darren M. Ashcroft, Kath D. Watson, Deborah P. M. Symmons, Peter R. Noyce & Kimme L. Hyrich. (2010) Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies. Arthritis Care & Research 62:3, pages 345-353.
Crossref
L. Dubertret, S. Chimenti, E. Christophers, E. Daudén, M. de Rie, C. E. M. Griffiths, K. Kragballe, M. Ståhle & G. Stingl. (2009) Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts. British Journal of Dermatology 161, pages 1-30.
Crossref
M.K.A. Basra, R. Fenech, R.M. Gatt, M.S. Salek & A.Y. Finlay. (2008) The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. British Journal of Dermatology.
Crossref
A. K. Andersson, M. Feldmann & F. M. Brennan. (2008) Neutralizing IL-21 and IL-15 Inhibits Pro-inflammatory Cytokine Production in Rheumatoid Arthritis. Scandinavian Journal of Immunology 68:1, pages 103-111.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.